Stockhub

Newron Pharmaceuticals S.p.A.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 19:2519:25, 21 September 2022 95.149.241.133 talk 725 bytes +725 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophr..."
Retrieved from "https://stockhub.co/research/Newron_Pharmaceuticals_S.p.A."